Clinical Trials Directory

Trials / Terminated

TerminatedNCT00767936

Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma

Viral and Host Factors Associated With Development of Hepatitis B Virus-related Hepatocellular Carcinoma

Status
Terminated
Phase
Study type
Observational
Enrollment
135 (actual)
Sponsor
Stanford University · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chronic HBV infection. The goal is to identify mutations in the HBV genome that predisposes these high risk individuals to the development of liver cancer.

Conditions

Timeline

Start date
2008-03-01
Primary completion
2013-03-01
Completion
2013-09-01
First posted
2008-10-07
Last updated
2016-06-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00767936. Inclusion in this directory is not an endorsement.